APELLIS PHARMACEUTICALS INC

CUSIP: 03753UAB2 Class: NOTE 3.500% 9/1

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,000,000 Value ($000) $5,164 Avg Close Range
Q3 2025
Shares 5,000,000 Value ($000) $5,151 Avg Close Range
Q2 2025
Shares 5,000,000 Value ($000) $5,005 Avg Close Range
Q1 2025
Shares 5,000,000 Value ($000) $5,251 Avg Close Range
Q4 2024
Shares 5,000,000 Value ($000) $5,789 Avg Close Range
Q3 2024
Shares 5,000,000 Value ($000) $5,546 Avg Close Range
Q2 2024
Shares 5,000,000 Value ($000) $6,314 Avg Close Range
Q1 2024
Shares 5,000,000 Value ($000) $8,162 Avg Close Range
Q4 2023
Shares 5,000,000 Value ($000) $8,165 Avg Close Range
Q3 2023
Shares 5,000,000 Value ($000) $6,267 Avg Close Range
Q2 2023
Shares 5,000,000 Value ($000) $11,995 Avg Close Range
Q2 2021
Shares 37,000,000 Value ($000) $68,858 Avg Close Range